Guardant Health, Inc. (GH) ownership: insiders 0% · institutions 98% · index and ETF funds 8% (13F 2026-03-31). Insider activity, 90 days: Insiders bought (45 sales, 1 open-market buys). 1 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Vanguard | 12552763.00 | $1.16B | 9.4% | 2026-03-31 |
| BlackRock | 11553759.00 | $1.07B | 8.6% | 2026-03-31 |
| Invesco | 4946469.00 | $456.91M | 3.7% | 2026-03-31 |
| Goldman Sachs | 4435839.00 | $409.74M | 3.3% | 2026-03-31 |
| Two Sigma | 4229531.00 | $390.68M | 3.2% | 2026-03-31 |
| FMR (Fidelity) | 4116081.00 | $380.20M | 3.1% | 2026-03-31 |
| Baillie Gifford | 3859046.00 | $356.46M | 2.9% | 2026-03-31 |
| Geode Capital Management | 3508883.00 | $324.17M | 2.6% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-21 | |
| Sell | null | 2026-08-21 | |
| Sell | null | 2026-08-21 | |
| Sell | null | 2026-08-21 | |
| Sell | null | 2026-08-21 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-15 |
Back to GH overview · GH earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.